-
EP3998284
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3998284
| EP3998284 - COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING IMMUNE CHECKPOINT INHIBITOR-RESISTANT CANCER [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.04.2022 Database last updated on 31.08.2024 | |
| Former | The international publication has been made Status updated on 18.01.2021 | Most recent event Tooltip | 24.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Good T Cells, Inc. (Shinchon-dong, Yonsei University Department of Biotechnology The 2nd Engineering Building) B528, B519 50, Yonsei-ro Seodaemun-gu Seoul 03722 / KR | [2022/19] | Inventor(s) | 01 /
KIM, Beom Seok Seogyo-dong) 206-ho, 21, Donggyo-ro 12-gil Mapo- gu Seoul 04029 / KR | 02 /
KIM, Jung Ho Daeheung-dong) 202-ho, 104, Daeheung-ro Mapo-gu Seoul 04136 / KR | [2022/19] | Representative(s) | Schnappauf, Georg ZSP Patentanwälte PartG mbB Hansastraße 32 80686 München / DE | [2022/19] | Application number, filing date | 20837734.1 | 13.07.2020 | [2022/20] | WO2020KR09181 | Priority number, date | KR20190084098 | 11.07.2019 Original published format: KR 20190084098 | [2022/19] | Filing language | KO | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021006714 | Date: | 14.01.2021 | Language: | KO | [2021/02] | Type: | A1 Application with search report | No.: | EP3998284 | Date: | 18.05.2022 | Language: | EN | [2022/20] | Search report(s) | International search report - published on: | KR | 14.01.2021 | (Supplementary) European search report - dispatched on: | EP | 04.07.2023 | Classification | IPC: | C07K16/28, A61K47/68, A61P35/00, A61K39/00 | [2022/19] | CPC: |
A61P35/00 (EP,CN,KR,US);
C07K16/28 (CN,KR);
A61K39/395 (CN,KR);
A61K45/06 (CN,US);
A61K47/68 (CN);
A61K47/6803 (KR);
A61K47/6849 (EP,US);
A61K47/6879 (EP,CN);
C07K16/18 (US);
C07K16/2803 (EP);
C07K16/2818 (EP);
C12Q1/6886 (KR);
G01N33/57496 (KR);
G01N33/6893 (KR);
A61K2039/505 (CN,KR,US);
A61K2039/507 (EP);
A61K39/00 (EP,CN,US);
C07K2317/34 (EP,KR);
C07K2317/622 (EP);
C07K2317/73 (EP);
C07K2317/76 (EP);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/19] | Title | German: | ZUSAMMENSETZUNG ZUR VORBEUGUNG, BESSERUNG ODER BEHANDLUNG VON IMMUNCHECKPOINT-INHIBITOR-RESISTENTEM KREBS | [2022/19] | English: | COMPOSITION FOR PREVENTING, AMELIORATING OR TREATING IMMUNE CHECKPOINT INHIBITOR-RESISTANT CANCER | [2022/19] | French: | COMPOSITION POUR LA PRÉVENTION, L'ATTÉNUATION OU LE TRAITEMENT DU CANCER RÉSISTANT AUX INHIBITEURS DE POINT DE CONTRÔLE IMMUNITAIRE | [2022/19] | Entry into regional phase | 10.01.2022 | Translation filed | 10.01.2022 | National basic fee paid | 10.01.2022 | Search fee paid | 10.01.2022 | Designation fee(s) paid | 10.01.2022 | Examination fee paid | Examination procedure | 10.01.2022 | Examination requested [2022/20] | 23.01.2024 | Amendment by applicant (claims and/or description) | 23.01.2024 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 12.07.2022 | Renewal fee patent year 03 | 24.07.2023 | Renewal fee patent year 04 | 24.07.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]KR20140013873 (SAMSUNG ELECTRONICS CO LTD [KR]); | [A]US2015239964 (LEE SANG-KYOU [KR]); | [A]WO2015187359 (NGM BIOPHARMACEUTICALS INC [US]); | [A]KR20180105232 (UNIV MIE [JP], et al); | [X]KR20180117067 (GOODTCELL CO LTD [KR]); | by applicant | KR20190084098 |